Healthcare

The S&P/ASX 200 Health Care sector closed Wednesday, May 13, 2026 at 22,690.20, up 0.22% on the day. The modest gain provided a measure of stability for the sector on a session marked by significant dispersion across the broader Australian sharemarket, with the headline …

EBR Systems Inc (ASX:EBR) advanced sharply on Wednesday as the medical device company outperformed the broader Australian sharemarket during another weaker session for the benchmark ASX 200. The stock closed at AUD 0.58, up 9.52 per cent for the day, positioning EBR among the …

The Q3 FY2026 report covering the period ended 31 March 2026 details activity across three clinical programs: the CPACS Phase 1 trial assessing RC220 in cardioprotection alongside anticancer treatment, the HARNESS-1 Phase 1 trial for lung cancer, and preparatory work for the AML (acute …

Nexsen Limited (ASX:NXN) shares moved sharply higher during the morning session on 13 May 2026, climbing 16.22% to AUD 0.22 after the company announced a strategic collaboration with GHK Hospital Limited, aSubsidiaryof multinational healthcare provider IHH Healthcare Berhad.

Healius Limited (ASX:HLS) traded at $0.40 on the ASX on 13 May 2026, recording an intraday decline of over 18%. With this, HLS share price has declined by approximately 63% over the preceding 12 months.

Telix Pharmaceuticals (ASX:TLX) traded lower on 12 May, falling 3.48% to AUD 14.43 as selling pressure intensified across the Australian healthcare sector. The move placed Telix among the weaker-performing ASX biotech names during a session marked by broader market caution and sector rotation.

The decline occurred despite the absence of any materially negative company-specific announcement. Instead, the weakness appeared largely tied to broader healthcare sector selling, valuation concerns, and reduced investor appetite for higher-BetaGrowth Stocks.